Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF)  | HRSA 26 012

Opportunity Information: Apply for HRSA 26 012

The Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF) is a discretionary grant opportunity from the Health Resources and Services Administration (HRSA) designed to help states and territories protect access to HIV medications and related coverage for low-income people with HIV. ADAP is a core part of the Ryan White system and typically functions as a payer of last resort that helps eligible clients obtain HIV-related medications and, in many places, health insurance or other health care coverage support. This ERF funding is specifically meant to stabilize ADAP programs when demand or costs spike, so that clients do not lose access to treatment due to budget shortfalls or the creation of waiting lists.

The purpose of the ERF awards is narrow and urgent: to prevent, reduce, or eliminate ADAP waiting lists, and/or to address ADAP financial shortfalls that threaten uninterrupted access to therapy. The program recognizes that states and territories can face sudden pressures, such as higher-than-expected enrollment, rising drug costs, or increased numbers of people needing assistance because of new HIV diagnoses, re-engagement in care, income loss, or loss of health insurance coverage. It also explicitly notes that awards may be used to address a projected increase in treatment needs aligned with the federal Ending the HIV Epidemic in the U.S. initiative, signaling that jurisdictions experiencing growth in need tied to that effort may justify emergency support.

Funds are intended to be used in conjunction with the existing Ryan White Part B ADAP, not as a stand-alone program. In practical terms, the ERF dollars can support access to medications either by direct purchase of medications or by providing health care coverage assistance (for example, premium and cost-sharing assistance where allowed under ADAP rules and state design). The overall focus is continuity of HIV treatment and preventing gaps in access that can worsen health outcomes and increase HIV transmission risk.

Eligibility is limited to Ryan White Part B state and territorial recipients that can demonstrate they meet one or more specific need-based conditions. Applicants must show that they require additional funding to do at least one of the following: reduce or eliminate an existing ADAP waiting list; actively prevent the implementation of a waiting list; address a projected increase in treatment needs consistent with Ending the HIV Epidemic goals; or respond to other unanticipated increases in client demand driven by factors like new diagnoses, people returning to care, or economic and coverage disruptions. States or territories that do not currently meet at least one of these criteria are not eligible to apply. Tribes and tribal organizations are explicitly not eligible for this particular funding opportunity.

The eligible applicant pool otherwise spans all 50 states, the District of Columbia, and multiple U.S.-affiliated jurisdictions and freely associated states, including the Commonwealth of Puerto Rico, U.S. Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands, as long as they are Part B recipients and meet the need requirements described above. The opportunity is listed under CFDA 93.917 and categorized as a health-focused grant program.

Key administrative details provided include the funding opportunity title and number (HRSA-26-012), an application closing date of 2025-11-03, an award ceiling of up to $10,000,000 per award, and an expectation of approximately 25 awards. The posting indicates it was created on 2025-10-02. Overall, this opportunity is best understood as a targeted emergency funding mechanism meant to quickly bolster ADAP programs facing immediate or near-term capacity and financing challenges, with the goal of keeping people with HIV connected to life-saving medication and coverage without interruption.

• The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF) " and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.917.
• This funding opportunity was created on 2025-10-02.
• Applicants must submit their applications by 2025-11-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $10,000,000.00 in funding.
• The number of recipients for this funding is limited to 25 candidate(s).
• Eligible applicants include: Others.

Apply for HRSA 26 012

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: